BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37153155)

  • 1. Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates.
    Cruz C; Rodrigues L; Fernandes F; Santos R; Paixão P; Chasqueira MJ
    Front Cell Infect Microbiol; 2023; 13():1141115. PubMed ID: 37153155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes.
    Vandewalle-Capo M; Massip C; Descours G; Charavit J; Chastang J; Billy PA; Boisset S; Lina G; Gilbert C; Maurin M; Jarraud S; Ginevra C
    Int J Antimicrob Agents; 2017 Nov; 50(5):684-689. PubMed ID: 28782709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility testing reveals reduced susceptibility to azithromycin and other antibiotics in Legionella pneumophila serogroup 1 isolates from Portugal.
    Minetti C; Barton R; Farley C; Spiller OB; Rodrigues R; Gonçalves P
    Eur J Clin Microbiol Infect Dis; 2024 May; ():. PubMed ID: 38696083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Susceptibility of Environmental
    Cocuzza CE; Martinelli M; Perdoni F; Giubbi C; Vinetti MEA; Calaresu E; Frugoni S; Scaturro M; Ricci ML; Musumeci R
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501942
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial susceptibility profiles and tentative epidemiological cutoff values of
    Yang JL; Sun H; Zhou X; Yang M; Zhan XY
    Front Microbiol; 2022; 13():924709. PubMed ID: 36312931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type MIC distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates.
    Bruin JP; Ijzerman EP; den Boer JW; Mouton JW; Diederen BM
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):103-8. PubMed ID: 22100012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibility of environmental
    Sreenath K; Chaudhry R; Vinayaraj EV; Thakur B
    Future Microbiol; 2019 May; 14():661-669. PubMed ID: 31148475
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antimicrobial susceptibility patterns of Legionella isolates in the environment and in patients].
    Choi GE; Kang JE; Lee EY; Chang CL; Tateda K; Yamaguchi K; Kim KH; Kim JM
    Korean J Lab Med; 2010 Feb; 30(1):28-33. PubMed ID: 20197719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin.
    Reda C; Quaresima T; Pastoris MC
    J Antimicrob Chemother; 1994 Apr; 33(4):757-64. PubMed ID: 8056694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of macrolides against intracellular Legionella pneumophila.
    Segreti J; Meyer P; Kapell K
    Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of antibiotic susceptibility of Legionella pneumophila isolated from water systems in Poland.
    Sikora A; Gładysz I; Kozioł-Montewka M; Wójtowicz-Bobin M; Stańczak T; Matuszewska R; Krogulska B
    Ann Agric Environ Med; 2017 Mar; 24(1):66-69. PubMed ID: 28378991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility study of BMS-284756 against Legionella species.
    Dubois J; St-Pierre C
    Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of antimicrobial agents against Legionella isolated from environmental water systems: first results from Turkey.
    Erdogan H; Can F; Demirbilek M; Timurkaynak F; Arslan H
    Environ Monit Assess; 2010 Dec; 171(1-4):487-91. PubMed ID: 20049525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Resistance and Azithromycin Resistance Mechanism of Legionella pneumophila Serogroup 1 in China.
    Jia X; Ren H; Nie X; Li Y; Li J; Qin T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic sensitivity of environmental Legionella pneumophila strains isolated in Poland.
    Gładysz I; Sikora A; Wójtowicz-Bobin M; Szepeluk A; Matuszewska R; Bartosik M; Karczewski JK
    Ann Agric Environ Med; 2023 Dec; 30(4):602-605. PubMed ID: 38153060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Susceptibility Patterns of
    Assaidi A; Ellouali M; Latrache H; Timinouni M; Zahir H; Karoumi A; Barguigua A; Mliji EM
    Microb Drug Resist; 2020 Aug; 26(8):991-996. PubMed ID: 32125920
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
    Stout JE; Arnold B; Yu VL
    Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of MIC value and disk inhibition zone diameters in clinical Legionella pneumophila serogroup 1 isolates.
    Bruin JP; Diederen BM; Ijzerman EP; Den Boer JW; Mouton JW
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):339-42. PubMed ID: 23583350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
    Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
    Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
    Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
    J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.